Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12609000484246
Ethics application status
Approved
Date submitted
12/06/2009
Date registered
18/06/2009
Date last updated
18/06/2009
Type of registration
Retrospectively registered
Titles & IDs
Public title
Single blinded evaluation of the effectiveness of Neuro Psycho Physical Optimization protocol with Radio Electric Asymmetric Conveyer in stress-related disorders, assessed with Symptom Checklist-90 (SCL-90) and Psychological Stress Measure Test.
Query!
Scientific title
Single blinded evaluation of the effectiveness of Neuro Psycho Physical Optimization protocol with Radio Electric Asymmetric Conveyer in stress-related disorders, assessed with Symptom Checklist-90 (SCL-90) and Psychological Stress Measure Test.
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
sbsclmsp
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
emotional and psychophysical disorders stress related
236981
0
Query!
Condition category
Condition code
Mental Health
237324
237324
0
0
Query!
Other mental health disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
The intervention comprises: A cycle of auricular treatment protocol with Radioelectric Asymetric Conveyer (REAC). The REAC is a Radioelectric medical device. The protocol used, called Neuro Psycho Physical Optimization (ONPF), involves the application of a probe of the REAC on specific points of the auricular pavilion for an activation time of roughly 500 mms. The ONPF protocol is activated in a precise sequence on seven auricular points. . The protocol envisages 18 sessions of ONPF treatment lasting approximately 3,5 seconds each on alternating days, for eight (8) weeks. Assessment, at baseline and immediately at the end of treatment, with SCL-90 and Psychological Stress Measure Test
Query!
Intervention code [1]
236748
0
Treatment: Devices
Query!
Comparator / control treatment
Evaluate the effectiveness on the subjective perception of stress and stress-related symptom between the treated group and the placebo group (treted with inactive REAC).The inactive REAC is the exact same machine but with a modified probe. The frequency and overall duration in which the inactive REAC will be applied, is the same as for the intervention group, 18 sessions of treatment on alternating days lasting 3,5 seconds per session for eight (8) weeks.
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
238144
0
To test if the use of the Neuro Psycho Physical Optimization (ONPF) auricular protocol with REAC - is effective in reducing the subjective perception of stress, and stress-related symptoms, assessed with SCL-90 and Psychological Stress Measure Test
Query!
Assessment method [1]
238144
0
Query!
Timepoint [1]
238144
0
At time zero and immediatly after the therapy cycle.
Query!
Secondary outcome [1]
242358
0
Wellbeing assessed with Psychological stress measure test (PSM)
Query!
Assessment method [1]
242358
0
Query!
Timepoint [1]
242358
0
At time zero and immediatly after the therapy cycle.
Query!
Eligibility
Key inclusion criteria
Healthy Subjects without organic diseases, over 18 years old, who claimed to be stressed, with any type of stress-related symptoms and with Psychological stress measure test (PSM) total score over 45 points. No history of drug abuse, nor severe mental illness or personality disorder. No medications, known to affect cognitive functioning nor undergoing psychological interventions.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Diagnosis of psychiatric pathology, organic central nervous system (CNS) pathology, preceding skull traumas with loss of conscience longer than 5 minutes, dementia, alcohol dependence, current therapy with medications known to affect cognitive functioning.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The subjects, blindway, was allocated randomly to treatment or control group by an external operator
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation by an external operator - computerized sequence generation at the reception desk
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Only doctors who administered treatment knew whether it was real or placebo. The normal and the placebo REAC device will be indistinguishable.
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
2/12/2003
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
120
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
1832
0
Italy
Query!
State/province [1]
1832
0
Query!
Funding & Sponsors
Funding source category [1]
237143
0
Charities/Societies/Foundations
Query!
Name [1]
237143
0
Istituto Rinaldi Fontani
Query!
Address [1]
237143
0
Via Nazionale 23, 50123 Firenze
Query!
Country [1]
237143
0
Italy
Query!
Primary sponsor type
Charities/Societies/Foundations
Query!
Name
Istituto Rinaldi Fontani
Query!
Address
Via Nazionale 23, 50123 Firenze
Query!
Country
Italy
Query!
Secondary sponsor category [1]
4634
0
Charities/Societies/Foundations
Query!
Name [1]
4634
0
Societa di Ottimizzazione Neuro Psico Fisica e CRM Terapia
Query!
Address [1]
4634
0
Via Nazionale 23, 50123 Firenze
Query!
Country [1]
4634
0
Italy
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
239236
0
Societa di Ottimizzazione Neuro Psico Fisica e CRM Terapia
Query!
Ethics committee address [1]
239236
0
Via Nazionale 23 50123 Firenze
Query!
Ethics committee country [1]
239236
0
Italy
Query!
Date submitted for ethics approval [1]
239236
0
Query!
Approval date [1]
239236
0
Query!
Ethics approval number [1]
239236
0
Query!
Summary
Brief summary
The aim of this study is evaluate the efficacy of the Neuro Psycho Physical Optimization (NPPO) protocol treatment with Radioelectric Asymmetric Conveyer (REAC) in the improvement of the psychic and symptomatic stress-related disorders in a group of subjects revealing high values of psychological stress. These randomized, single-blinded controlled study, was conducted on subjects that voluntarily came to our Institute declaring to “feel stressed”. One hundred twenty four (124) subjects (females, n = 81, males, n = 43) with psychological distress symptoms, were recruited an randomized to REAC therapy or placebo.
Eighteen sessions of NPPO protocol treatment with REAC, or placebo (inactivated REAC), was applied to seven specific points of the auricular pavilion and were administered on alternate days, lasting about four weeks. Psychological stress symptoms were assessed by Psychological Stress Measure (PSM) and Symptomatic Check List (SCL-90), pre and post intervention. Data were analyzed using the Statistical Package for Social Sciences (SPSS), version 13.0
Data conformed to a Gaussian distribution. There was a significant reduction in PSM test and SCL-90 scores in the treated group as compared to the placebo group. Results of the psychometric tests showed that the subjects that underwent the effective therapy showed a statistically relevant reduction in their level of stress and psychological disorders compared to the control placebo group.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
29736
0
Query!
Address
29736
0
Query!
Country
29736
0
Query!
Phone
29736
0
Query!
Fax
29736
0
Query!
Email
29736
0
Query!
Contact person for public queries
Name
12983
0
Fontani Vania M.D.
Query!
Address
12983
0
Via Nazionale 23 50123 Firenze
Query!
Country
12983
0
Italy
Query!
Phone
12983
0
+39 055 290307
Query!
Fax
12983
0
Query!
Email
12983
0
[email protected]
Query!
Contact person for scientific queries
Name
3911
0
Salvatore Rinaldi M.D.
Query!
Address
3911
0
Via Nazionale 23 50123 Firenze
Query!
Country
3911
0
Italy
Query!
Phone
3911
0
+39 055 290307
Query!
Fax
3911
0
Query!
Email
3911
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF